Current status of excision repair cross complementing-group 1 (ERCC1) in cancer

This publication has 110 references indexed in Scilit:

• Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers
  Carcinogenesis: Integrative Cancer Research, 2007
• First Reported Patient with Human ERCC1 Deficiency Has Cerebro-Oculo-Facio-Skeletal Syndrome with a Mild Defect in Nucleotide Excision Repair and Severe Developmental Failure
  American Journal of Human Genetics, 2007
• Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: A complex genotype–phenotype relationship
  Published by Elsevier ,2007
• Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
  Annals of Oncology, 2007
• Molecular mechanisms of resistance and toxicity associated with platinating agents
  Published by Elsevier ,2006
• Molecular Mechanisms of Mammalian Global Genome Nucleotide Excision Repair
  Chemical Reviews, 2005
• Nucleotide Excision Repair
  Progress in Nucleic Acid Research and Molecular Biology, 2005
• Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines
  International Journal of Cancer, 2004
• Cisplatin: mode of cytotoxic action and molecular basis of resistance
  Oncogene, 2003
• Purification and Characterization of the XPF-ERCC1 Complex of Human DNA Repair Excision Nuclease
  Published by Elsevier ,1995